14.12.2018
Test method for active substances and finished medicinal products
13.12.2018
Continuation of harmonisation efforts in an increasingly global International Council for Harmonisation
04.12.2018
More medicines available for sale over the counter – Patient safety paramount
29.11.2018
Eingabefrist: 25. Januar 2019
23.11.2018
Presence of impurities in recalled valsartan products now proven
16.11.2018
The prevailing supply category C will be eliminated.
14.11.2018
Swissmedic laboratory discovers contamination with N-nitrosodiethylamine above the tolerated level in certain valsartan batches
06.11.2018
Keywords in this edition: Isotretinoin, DOAC, confusions amphotericin B formulations, guest articles RPVC, transfusion practice, statistical review 2017
05.11.2018
Analytical results to date for the proprietary medicinal products containing the active substances valsartan, losartan, olmesartan, candesartan and irbesartan
14.12.2018
Test method for active substances and finished medicinal products
13.12.2018
Continuation of harmonisation efforts in an increasingly global International Council for Harmonisation
04.12.2018
More medicines available for sale over the counter – Patient safety paramount
29.11.2018
Eingabefrist: 25. Januar 2019
23.11.2018
Presence of impurities in recalled valsartan products now proven
16.11.2018
The prevailing supply category C will be eliminated.
14.11.2018
Swissmedic laboratory discovers contamination with N-nitrosodiethylamine above the tolerated level in certain valsartan batches
06.11.2018
Keywords in this edition: Isotretinoin, DOAC, confusions amphotericin B formulations, guest articles RPVC, transfusion practice, statistical review 2017
05.11.2018
Analytical results to date for the proprietary medicinal products containing the active substances valsartan, losartan, olmesartan, candesartan and irbesartan
